Medline ® Abstract for Reference 45
of 'Toxicities associated with checkpoint inhibitor immunotherapy'
45
Hammers HJ, Plimack ER, Infante JR, et al. Phase I study of nivolumab in combination with ipilimumab in metastatic renal cell carcinoma. J Clin Oncol 32:5s, 2014 (suppl; abstr 4504)
no abstract available